E. Assier

发表

Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft‐versus‐host disease to HLA‐DR–mediated cell death

H. Greinix, N. Setterblad, D. Charron, 2007, Transfusion.

Interleukin-6: from identification of the cytokine to development of targeted treatments.

J. Dayer, E. Assier, M. Boissier, 2010, Joint, bone, spine : revue du rhumatisme.

Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells

N. Setterblad, A. Galy, D. Charron, 2008, European journal of immunology.

Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis

S. Muller, H. Hlawaty, E. Assier, 2015, Angiogenesis.

Anti-cytokine vaccination in autoimmune diseases.

E. Assier, M. Boissier, L. Semerano, 2010, Swiss medical weekly.

Emerging applications of anticytokine vaccines

E. Assier, N. Bessis, M. Boissier, 2008, Expert review of vaccines.

Arthritis models: usefulness and interpretation

E. Assier, P. Decker, N. Bessis, 2017, Seminars in Immunopathology.

Modulation of Anti-Tumor Necrosis Factor Alpha (TNF-α) Antibody Secretion in Mice Immunized with TNF-α Kinoid

E. Assier, P. Larcier, N. Bessis, 2012, Clinical and Vaccine Immunology.

IL-2 production by myofibroblasts from post-radiation fibrosis in breast cancer patients.

D. Métivier, C. Jasmin, A. Alileche, 1994, International immunology.

L-2 production by myofibroblasts from post-radiation in breast cancer patients

D. Métivier, C. Jasmin, E. Assier, 1994 .

Modulation of anti-TNF-alpha antibody secretion in mice immunized with TNF- 4

E. Assier, P. Larcier, N. Bessis, 2012 .

Early and long-lasting protection from arthritis in tumour necrosis factor α (TNFα) transgenic mice vaccinated against TNFα

D. Zagury, E. Assier, B. Bizzini, 2007 .

Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis

E. Assier, M. Boissier, L. Semerano, 2011, Expert opinion on biological therapy.

TLR7/8 agonists impair monocyte‐derived dendritic cell differentiation and maturation

D. Charron, E. Maggi, V. Marin‐Esteban, 2007, Journal of leukocyte biology.

Vaccination with cytokines in autoimmune diseases

J. Zagury, S. Muller, E. Assier, 2008, Annals of medicine.

Vaccinating against TNF a : a challenge for the inflammatory diseases

J. Zagury, S. Muller, E. Assier, 2008 .

Syndrome IL-2-Induced Pulmonary Vascular Leak Neutrophils Are Both Critical for NK Cells and Polymorphonuclear and

B. Vargaftig, J. Thèze, E. Assier, 2004 .

IL-1 Vaccination Is Suitable for Treating Inflammatory Diseases

J. Zagury, E. Assier, N. Bessis, 2017, Front. Pharmacol..

Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm.

E. Assier, N. Bessis, M. Boissier, 2008, Joint, bone, spine : revue du rhumatisme.

Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome.

B. Vargaftig, J. Thèze, J. R. Lapa e Silva, 2005, Cytokine.

Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis

S. Muller, H. Hlawaty, E. Assier, 2015, Angiogenesis.

Anti-cytokine vaccination: a new biotherapy of autoimmunity?

E. Assier, M. Boissier, L. Semerano, 2012, Autoimmunity reviews.

Active immunization against IL-23p19 improves experimental arthritis.

J. Zagury, R. Ratsimandresy, E. Assier, 2011, Vaccine.

Blood vessels, a potential therapeutic target in rheumatoid arthritis?

E. Assier, M. Boissier, G. Clavel, 2011, Joint, bone, spine : revue du rhumatisme.

Active immunization to tumor necrosis factor-α is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis

G. Vuagniaux, D. Zagury, E. Assier, 2009, Arthritis research & therapy.

Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalpha.

D. Zagury, E. Assier, B. Bizzini, 2008, Annals of the rheumatic diseases.

Protection from articular damage by passive or active anti‐tumour necrosis factor (TNF)‐α immunotherapy in human TNF‐α transgenic mice depends on anti‐TNF‐α antibody levels

J. Biton, E. Assier, O. Dhellin, 2013, Clinical and experimental immunology.

Regulatory T cells (Treg) in rheumatoid arthritis.

Eric Assier, Marie-Christophe Boissier, Géraldine Falgarone, 2009, Joint, bone, spine : revue du rhumatisme.

Interleukin-23: A key cytokine in inflammatory diseases

E. Assier, M. Boissier, G. Falgarone, 2011, Annals of medicine.

Isolation, sequencing and expression of RED, a novel human gene encoding an acidic-basic dipeptide repeat.

J. Trowsdale, P. Freemont, D. Charron, 1999, Gene.

NK Cells and Polymorphonuclear Neutrophils Are Both Critical for IL-2-Induced Pulmonary Vascular Leak Syndrome1

J. D. Di Santo, B. Vargaftig, J. Thèze, 2004, The Journal of Immunology.

A new cytokine (IK) down-regulating HLA class II: monoclonal antibodies, cloning and chromosome localization.

C. Jasmin, M. Merck, C. Boucheix, 1994, Oncogene.

Disassembly of nuclear inclusions in the dividing cell--a novel insight into neurodegeneration.

J. Trowsdale, J. Skepper, D. Charron, 1999, Human molecular genetics.

A1.36 Active immunisation against peptides of vegf improves joint inflammation and destruction in collagen-induced arthritis

S. Muller, E. Assier, N. Schall, 2014 .

Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection

B. Ryffel, D. Damotte, E. Assier, 2017, Front. Immunol..

Inhibitor (IK) of IFN-γ induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line

C. Jasmin, D. Charron, E. Assier, 1997, Oncogene.

E. Assier, S. Dastidar, M. Boissier, 2012 .